BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 11226151)

  • 1. The fusion domain of HIV gp41 interacts specifically with heparan sulfate on the T-lymphocyte cell surface.
    Cladera J; Martin I; O'Shea P
    EMBO J; 2001 Jan; 20(1-2):19-26. PubMed ID: 11226151
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Conformational stability and membrane interaction of the full-length ectodomain of HIV-1 gp41: implication for mode of action.
    Lev N; Fridmann-Sirkis Y; Blank L; Bitler A; Epand RF; Epand RM; Shai Y
    Biochemistry; 2009 Apr; 48(14):3166-75. PubMed ID: 19206186
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mediation of human immunodeficiency virus type 1 binding by interaction of cell surface heparan sulfate proteoglycans with the V3 region of envelope gp120-gp41.
    Roderiquez G; Oravecz T; Yanagishita M; Bou-Habib DC; Mostowski H; Norcross MA
    J Virol; 1995 Apr; 69(4):2233-9. PubMed ID: 7884870
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of the fusion peptide and membrane-proximal domain in HIV-1 envelope glycoprotein-mediated membrane fusion.
    Dimitrov AS; Rawat SS; Jiang S; Blumenthal R
    Biochemistry; 2003 Dec; 42(48):14150-8. PubMed ID: 14640682
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cellular membrane-binding ability of the C-terminal cytoplasmic domain of human immunodeficiency virus type 1 envelope transmembrane protein gp41.
    Chen SS; Lee SF; Wang CT
    J Virol; 2001 Oct; 75(20):9925-38. PubMed ID: 11559825
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human herpesvirus 8 envelope-associated glycoprotein B interacts with heparan sulfate-like moieties.
    Akula SM; Pramod NP; Wang FZ; Chandran B
    Virology; 2001 Jun; 284(2):235-49. PubMed ID: 11384223
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional and structural characterization of HIV-1 gp41 ectodomain regions in phospholipid membranes suggests that the fusion-active conformation is extended.
    Korazim O; Sackett K; Shai Y
    J Mol Biol; 2006 Dec; 364(5):1103-17. PubMed ID: 17045292
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiviral properties of two trimeric recombinant gp41 proteins.
    Delcroix-Genête D; Quan PL; Roger MG; Hazan U; Nisole S; Rousseau C
    Retrovirology; 2006 Mar; 3():16. PubMed ID: 16515685
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Susceptibility to virus-cell fusion at the plasma membrane is reduced through expression of HIV gp41 cytoplasmic domains.
    Malinowsky K; Luksza J; Dittmar MT
    Virology; 2008 Jun; 376(1):69-78. PubMed ID: 18400243
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional analysis of the disulfide-bonded loop/chain reversal region of human immunodeficiency virus type 1 gp41 reveals a critical role in gp120-gp41 association.
    Maerz AL; Drummer HE; Wilson KA; Poumbourios P
    J Virol; 2001 Jul; 75(14):6635-44. PubMed ID: 11413331
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of cholesterol on the interaction of the HIV GP41 fusion peptide with model membranes. Importance of the membrane dipole potential.
    Buzón V; Cladera J
    Biochemistry; 2006 Dec; 45(51):15768-75. PubMed ID: 17176099
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of envelope processing and gp41 membrane spanning domain in the formation of human immunodeficiency virus type 1 (HIV-1) fusion-competent envelope glycoprotein complex.
    Welman M; Lemay G; Cohen EA
    Virus Res; 2007 Mar; 124(1-2):103-12. PubMed ID: 17129629
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of the interacting domain of the HIV-1 fusion peptide with the transmembrane domain of the T-cell receptor.
    Cohen T; Pevsner-Fischer M; Cohen N; Cohen IR; Shai Y
    Biochemistry; 2008 Apr; 47(16):4826-33. PubMed ID: 18376816
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Downregulation of human immunodeficiency virus type 1 Gag expression by a gp41 cytoplasmic domain fusion protein.
    Chan WE; Chen SS
    Virology; 2006 May; 348(2):418-29. PubMed ID: 16472834
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HIV-1 gp41: mediator of fusion and target for inhibition.
    Weiss CD
    AIDS Rev; 2003; 5(4):214-21. PubMed ID: 15012000
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interaction of fusion peptides from HIV gp41 with membranes: a time-resolved membrane binding, lipid mixing, and structural study.
    Buzón V; Padrós E; Cladera J
    Biochemistry; 2005 Oct; 44(40):13354-64. PubMed ID: 16201760
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interaction of a peptide derived from the N-heptad repeat region of gp41 Env ectodomain with model membranes. Modulation of phospholipid phase behavior.
    Pascual R; Contreras M; Fedorov A; Prieto M; Villalaín J
    Biochemistry; 2005 Nov; 44(43):14275-88. PubMed ID: 16245944
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of the interaction of two peptides from the N terminus of the NHR domain of HIV-1 gp41 with phospholipid membranes.
    Moreno MR; Guillén J; Pérez-Berna AJ; Amorós D; Gómez AI; Bernabeu A; Villalaín J
    Biochemistry; 2007 Sep; 46(37):10572-84. PubMed ID: 17711304
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The N-terminal 12 residue long peptide of HIV gp41 is the minimal peptide sufficient to induce significant T-cell-like membrane destabilization in vitro.
    Charloteaux B; Lorin A; Crowet JM; Stroobant V; Lins L; Thomas A; Brasseur R
    J Mol Biol; 2006 Jun; 359(3):597-609. PubMed ID: 16677669
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of the HIV-1 gp41 core-binding motif--HXXNPF.
    Huang JH; Liu ZQ; Liu S; Jiang S; Chen YH
    FEBS Lett; 2006 Sep; 580(20):4807-14. PubMed ID: 16904109
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.